Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Help & FAQ
Dansk
English
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Search by expertise, name or affiliation
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
Hans Carl Hasselbalch,
Morten Orebo Holmström
Center for Cancer Immune Therapy (CCIT)
63
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Polycythemia Vera
100%
Residual Neoplasm
82%
Interferon-alpha
77%
Interferons
71%
INCB018424
45%
Neoplasms
24%
Disease Progression
23%
Therapeutics
12%
Thrombocytosis
12%
Clinical Trials
12%
Primary Myelofibrosis
12%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10%
Hematologic Neoplasms
9%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
9%
Acute Myeloid Leukemia
9%
Protein-Tyrosine Kinases
8%
Vaccination
7%
Anti-Inflammatory Agents
7%
Bone Marrow
7%
Alleles
7%
Inflammation
5%
Safety
5%
DNA
5%
Pharmaceutical Preparations
3%